The efficacy and safety of PACU ultra-early IPC in preventing DVT in patients undergoing gynecological laparoscopic surgery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100044484

Enrollment

Unknown

Registered

2021-03-23

Start date

2021-04-01

Completion date

Unknown

Last updated

2021-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Venous Thrombosis

Interventions

A:Routine IPC treatment in ward after the surgery

B:IPC treatment before the surgery +Routine IPC treatment in ward after the surgery

C:IPC treatment after the surgery +Routine IPC treatment in ward after the surgery

D:IPC treatment before the surgery +IPC treatment after the surgery +Routine IPC treatment in ward after the surgery

Eligibility

Sex/Gender

Female

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients undergoing elective gynecological laparoscopic surgery (hysteromyoma surgery, total hysterectomy, pelvic dissection surgery) and other patients with an estimated operation time of more than 2 hours.

Exclusion criteria

Exclusion criteria: Patients with hypertension, hematopathy, history of venous thrombosis in lower extremities, history of varicose vein surgery, inflammation of lower extremities and abnormal preoperative coagulation function were combined. Patients using estrogen, pregnant patients.

Design outcomes

Primary

Measure	Time frame
diameter and velocity of femoral and popliteal veinvein;haemodynamics;fibrinogen and D-dimer;	—

Countries

China

Contacts

Public ContactLiu Yanchang

Shenzhen Maternity & Child Healthcare Hospital

lychang2014@163.com+86 13500056733

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026